Celecoxib and sulindac sulfide elicit anticancer effects on PIK3CA-mutated head and neck cancer cells through endoplasmic reticulum stress, reactive oxygen species, and mitochondrial dysfunction
Article in Biochemical Pharmacology (April 2024)
The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.
Celecoxib: Antiangiogenic and Antitumoral Action
Article in International Journal of Morphology (February 2024)
Modulation of autophagy and apoptosis can contribute to the anticancer effect of Abemaciclib/Celecoxib combination in colon cancer cells
Article in Medical Oncology (January 2024)